According to Assertio Therapeutics
's latest financial reports the company has $73.44 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $73.44 M | 13.09% |
2022-12-31 | $64.94 M | 76.42% |
2021-12-31 | $36.81 M | 77.09% |
2020-12-31 | $20.78 M | -50.64% |
2019-12-31 | $42.1 M | -62.05% |
2018-12-31 | $0.11 B | -13.38% |
2017-12-31 | $0.12 B | -27.8% |
2016-12-31 | $0.17 B | -15.42% |
2015-12-31 | $0.20 B | -62.5% |
2014-12-31 | $0.55 B | 105.72% |
2013-12-31 | $0.27 B | 307.01% |
2012-12-31 | $66.81 M | -22.44% |
2011-12-31 | $86.14 M | 22.46% |
2010-12-31 | $70.35 M | 0.87% |
2009-12-31 | $69.74 M | -15.01% |
2008-12-31 | $82.05 M | 53.48% |
2007-12-31 | $53.46 M | 69.41% |
2006-12-31 | $31.55 M | -46.58% |
2005-12-31 | $59.07 M | 226.28% |
2004-12-31 | $18.1 M | -59.09% |
2003-12-31 | $44.25 M | 118.89% |
2002-12-31 | $20.21 M | 292.58% |
2001-12-31 | $5.15 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | 30.56% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.82 M | -71.65% | ๐บ๐ธ USA |